ArticleEClinicalMedicine2020

Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries.

Valérie Schwœbel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.